Organogenesis Holdings Inc (ORGO) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $1.37 (+0.74%), Market cap $0.32B, 52-week low–high $2.24 ~ $6.54.
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United States. Its advanced wound care products include Affinity and Novachor, which are amnion and chorion placental allografts for use in the care of chronic and acute wounds as protective barriers and extracellular matrix (ECM) scaffolds; Apligraf, a bioengineered bi-layered skin substitute for the treatment of venous leg ulcers and diabetic foot ulcers (DFU); Dermagraft, a dermal substitute grown from human dermal fibroblasts to treat DFUs; NuShield, a dehydrated placental allograft and surgical barr
Financial statements, price targets, institutional (13F) holdings and related news for Organogenesis Holdings Inc are updated in real time on BlackAll Trade.
Organogenesis Holdings Inc trades at $1.37 (+0.74%). Real-time quotes and charts are available on BlackAll Trade.
Organogenesis Holdings Inc has a market cap of about $0.32B.
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the United St